Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
9/23/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
HRSA ,
Medicaid ,
Medicare ,
Mental Health ,
MHPAEA ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/29/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Healthcare Workers ,
HRSA ,
Life Sciences ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
Nursing Homes ,
Pharmaceutical Industry ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
2/26/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Medicaid ,
Medical Devices ,
Pharmaceutical Industry ,
Popular ,
Public Health Emergency
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
8/14/2023
/ Clinical Trials ,
DEA ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicare ,
National Institute of Health (NIH) ,
Nurses ,
OCR ,
Prescription Drugs ,
Substance Abuse
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
7/17/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Child Care ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Medicaid ,
Medicare ,
OPPS ,
Popular
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
5/30/2023
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Insurance ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
OIG ,
SAMHSA
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
5/8/2023
/ Biosimilars ,
Centers for Disease Control and Prevention (CDC) ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
EMTALA ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
Medical Devices ,
National Institute of Health (NIH) ,
Popular ,
SAMHSA